Drug-resistant malaria spreading beyond Western Cambodia, U.S. malaria coordinator says

Resistance to artemisinin-based malaria medications seems to be spreading beyond western Cambodia, where it was first detected, U.S. global malaria coordinator Timothy Ziemer said during a visit to the region this week for a conference, Agence France-Presse reports.

First spotted in western Cambodia in 2007, there are now signs of artemisinin-resistance noted in southern Myanmar and potentially emerging resistance along the Chinese-Myanmar border and in southern Vietnam near Cambodia, according to Ziemer.

Still, the total number of malaria cases had fallen, Ziemer told the conference. "In Vietnam, for example, they were down from about 190,000 in 1991 to 15,000 by 2008, he said. 'But it is essential that national governments remain focused to contain and eventually eliminate these multi-drug resistant strains,' he told the conference on international cooperation against infectious diseases," AFP writes. Ziemer noted the importance of getting rid of counterfeit and substandard drugs, which increase resistance.

The WHO "warned early last year that parasites resistant to the drug artemisinin had emerged along the border between Cambodia and Thailand," according to the news service (6/18).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Egypt achieves historic malaria-free certification